Oxford Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Oxford Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16,923	Closed	-$795K	–	729
2025 Q2	$795K	Buy	16,923 +9,292	+122%	+$413K	0.26%	94
2025 Q1	$337K	Buy	+7,631	New	+$351K	0.15%	229
2020 Q1	$253K	Sell	9,355 -94,206	-91%	-$3.07M	0.04%	101
2019 Q4	$3.99M	Sell	103,561 -64,829	-38%	-$1.52M	0.11%	196
2019 Q3	$3.65M	Buy	+168,390	New	+$3.98M	0.09%	268

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Oxford Asset Management's SWTX Position: Q3 2025 in Review

Oxford Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 16,923 shares — an estimated $795K sold.

Oxford Asset Management first reported a position in SWTX in Q3 2019 and held it in 5 quarters. The position peaked at $3.99M in Q4 2019. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Oxford Asset Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Oxford Asset Management sold 16,923 SpringWorks Therapeutics shares in Q3 2025, an estimated $795K.
Oxford Asset Management first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 5 quarters.
Oxford Asset Management's SpringWorks Therapeutics position peaked at $3.99M in Q4 2019.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.